Want to join the conversation?
$COF said the Federal Reserve has approved its 2016 Comprehensive Capital Analysis & Review. $COF expects to maintain its quarterly dividend of $0.40 per share, subject to approval by its BoD. Additionally, $COF's BoD has authorized the repurchase of up to $2.5Bil of shares of its common stock beginning in 3Q16 through the end of 2Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.